Related Articles
Proteasome inhibitors differentially affect heat shock protein response in cancer cells
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
A COMMON PATHWAY FOR THE DESTRUCTION OF CANCER-CELLS - EXPERIMENTAL-EVIDENCE AND CLINICAL IMPLICATIONS
Enhanced antitumor immunity of nanoliposome-encapsulated heat shock protein 70 peptide complex derived from dendritic tumor fusion cells
HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review)